Phase I study of induction chemoimmunotherapy (ICI) with cemiplimab in combination with cisplatin and docetaxel (TPI) in patients with locally advanced squamous cell carcinoma of the head and neck (LA SCCHN).

Authors: Omayra Sanchez, Leslie Anne Worona, Emily J Ramos, Vruti Virani, Marshall R. Posner, Scott Roof, Kunal K. Sindhu, Richard Lorne Bakst, Eric Michael Genden, Krzysztof Misiukiewicz

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.e18116

Source: Full article

---

Abstract

e18116